|

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

RECRUITINGN/ASponsored by Washington University School of Medicine
Actively Recruiting
PhaseN/A
SponsorWashington University School of Medicine
Started2022-10-18
Est. completion2027-01-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Eligibility Criteria:

* Patients with cholangiocarcinoma, multiple myeloma, or early onset colon or rectal cancer.

  * If diagnosed with multiple myeloma, must be African-American.
  * If diagnosed with colon or rectal cancer, must be African-American AND must be no older than 65 years old at the time of diagnosis.
  * At least 18 years old
  * Able to understand and willing to sign an IRB-approved written informed consent document

Conditions5

CancerCholangiocarcinomaColon CancerMultiple MyelomaRectal Cancer

Locations1 site

Washington University School of Medicine
St Louis, Missouri, 63110
Graham Colditz, M.D., DrPH, MPH314-454-7939colditzg@wustl.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.